Status:
UNKNOWN
Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome
Lead Sponsor:
BioIncept LLC
Collaborating Sponsors:
Merck KGaA, Darmstadt, Germany
Conditions:
Pregnancy
Fertility
Eligibility:
FEMALE
18+ years
Brief Summary
PIF: biomarker of successful implantation To overcome the poor reproductive potential of embryos generated during in vitro fertilization cycles and the lack of markers enabling the identification of t...
Detailed Description
The aim of the proposed project is to investigate a non invasive biomarker, PIF (PreImplantation Factor), a 15amino acid peptide (MVRIKPGSANKPSDD) secreted only by viable embryos and placenta (Stamaki...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- All women included in our centers for classical IVF or ICSI, who will sign the written consent to participate in the study. PIF level evaluation in culture media (M) and pregnancy prognosis (S1 and S2) will be done only for women with SET.
- Exclusion criteria Women who will refuse to participate in the program.
Exclusion
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01803893
Start Date
September 1 2012
Last Update
March 4 2013
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Women and Children's Center for Blood Disorders & Yale Fertility Center
New Haven, Connecticut, United States, 06511
2
Poissy St Germain Hospital
Poissy, Cedex, France, 78303
3
Lab Clement - Seine St. Denis Hospital, Le Blanc Mesnil
Paris, France, 93150
4
Versailles St. Quentin University
Poissy, France, 2493